We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current N1VO34 market cap is 2.23T. The company's latest EPS is DKK 2.4362 and P/E is 34.79.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Revenue | 58.73B | 65.86B | 65.35B | 68.06B | 71.31B |
| Operating Income | 26.91B | 26.85B | 31.85B | 25.93B | 33.82B |
| Net Income | 22.48B | 21.96B | 25.41B | 20.05B | 27.3B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Revenue | 122.02B | 126.95B | 140.8B | 176.95B | 232.26B |
| Operating Income | 52.35B | 54.28B | 58.62B | 74.62B | 102.66B |
| Net Income | 38.95B | 42.14B | 47.76B | 55.53B | 83.68B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Assets | 300.1B | 314.49B | 298.92B | 369.38B | 397.44B |
| Total Liabilities | 207.11B | 207.93B | 200.01B | 256.86B | 276.92B |
| Total Equity | 92.99B | 106.56B | 98.91B | 112.52B | 120.52B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Assets | 125.61B | 144.92B | 194.51B | 241.26B | 314.49B |
| Total Liabilities | 68.02B | 81.6B | 123.76B | 157.77B | 207.93B |
| Total Equity | 57.59B | 63.33B | 70.75B | 83.49B | 106.56B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Operating | 99.36B | 108.91B | 14.31B | 64.82B | 108.67B |
| Investing | -29.18B | -43.89B | 3.96B | -16.78B | -37.68B |
| Financing | -53.04B | -63.16B | -26.38B | -9.7B | -28.1B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Operating | 46.78B | 51.95B | 55B | 78.89B | 108.91B |
| Investing | -11.51B | -22.44B | -31.61B | -24.92B | -43.89B |
| Financing | -35.48B | -32.24B | -25.49B | -51.8B | -63.16B |
| Market Cap | 2.23T |
| Price to Earnings Ratio | 34.79 |
| Price to Sales Ratio | 12.53 |
| Price to Cash Ratio | 202.27 |
| Price to Book Ratio | 27.32 |
| Dividend Yield | - |
| Shares Outstanding | 34.35B |
| Average Volume (1 week) | 6.19k |
| Average Volume (1 Month) | 7.34k |
| 52 Week Change | 5.72% |
| 52 Week High | 103.10 |
| 52 Week Low | 61.08 |
| Spread (Intraday) | 1.86 (2.79%) |
| Company Name | Novo Nordisk |
| Address |
novo alle bagsvaerd DK-2880 |
| Website | https://www.novonordisk.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
